DR. STEVEN JEFFREY SOLLOTT, MD
Osteopathic Medicine in Baltimore, MD
License number
Maryland D36062
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
5600 Nathan Shock Dr Gerontology Research Ctr, Baltimore, MD 21224
Phone
(410) 558-8202
(410) 558-8150 (Fax)
(410) 558-8150 (Fax)
Personal information
See more information about STEVEN JEFFREY SOLLOTT at radaris.comName
Address
Phone
2373 Sundew Ter, Baltimore, MD 21209
Baltimore, MD
2373 Sundew Ter, Baltimore, MD 21209
Professional information
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
6500859, Dec 31, 2002
Filed:
Apr 11, 2002
Appl. No.:
10/121500
Inventors:
James L. Kinsella - Baltimore MD
Steven J. Sollott - Baltimore MD
Steven J. Sollott - Baltimore MD
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
A61K 31337
US Classification:
514449, 549510, 549511, 514824
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Steven Jeffrey Sollott, Baltimore MD
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology, Family Medicine
Work:
National Institute On Aging
5600 Nathan Shock Dr, Baltimore, MD 21224
5600 Nathan Shock Dr, Baltimore, MD 21224
Education:
University of Rochester(1984)
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
2011019, Aug 4, 2011
Filed:
Apr 13, 2011
Appl. No.:
13/086277
Inventors:
James L. Kinsella - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
International Classification:
A61K 31/337, A61P 9/10
US Classification:
514449
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
2012008, Apr 12, 2012
Filed:
Dec 15, 2011
Appl. No.:
13/327548
Inventors:
James L. Kinsella - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
International Classification:
A61K 31/337, A61P 9/10
US Classification:
514449
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method Of Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
5616608, Apr 1, 1997
Filed:
Apr 18, 1996
Appl. No.:
8/633185
Inventors:
James L. Kinsella - Baltimore MD
Steven J. Sollott - Baltimore MD
Steven J. Sollott - Baltimore MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61K 31335, A61K 3308
US Classification:
514449
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
2003010, May 29, 2003
Filed:
Oct 15, 2002
Appl. No.:
10/272496
Inventors:
James Kinsella - Baltimore MD, US
Steven Sollott - Baltimore MD, US
Steven Sollott - Baltimore MD, US
Assignee:
The Gov't of the U.S.A. as Represented by the Secretary of the Dept. of Health and Human Service
International Classification:
A61K031/337, C 07D 3 5/14
US Classification:
514/449000, 549/510000
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method Of Treating Atherosclerosis Or Restenosis Using Microtube Stabilizing Agent
US Patent:
2006010, May 11, 2006
Filed:
Dec 14, 2005
Appl. No.:
11/304362
Inventors:
James Kinsella - Baltimore MD, US
Steven Sollott - Baltimore MD, US
Steven Sollott - Baltimore MD, US
International Classification:
A61K 31/337
US Classification:
514449000
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
2007012, May 31, 2007
Filed:
Dec 21, 2006
Appl. No.:
11/644411
Inventors:
James Kinsella - Baltimore MD, US
Steven Sollott - Baltimore MD, US
Steven Sollott - Baltimore MD, US
International Classification:
A61K 31/337
US Classification:
514449000
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or resenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Method For Treating Atherosclerosis Or Restenosis Using Microtubule Stabilizing Agent
US Patent:
2008019, Aug 14, 2008
Filed:
Feb 21, 2008
Appl. No.:
12/072067
Inventors:
James L. Kinsella - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
Steven J. Sollott - Baltimore MD, US
International Classification:
A61K 31/337, A61P 9/10
US Classification:
514449
Abstract:
The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
Dr. Steven J Sollott, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
National Institute On Aging
251 Bayview Blvd SUITE 100, Baltimore 21224
(410) 558-8573 (Phone)
251 Bayview Blvd SUITE 100, Baltimore 21224
(410) 558-8573 (Phone)
Certifications:
Cardiovascular Disease, 1989, Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Rochester
Graduated: 1984
Cornell Hosps
Johns Hopkins/Nih
University of Rochester
Graduated: 1984
Cornell Hosps
Johns Hopkins/Nih